Allergy Conjunctivitis Market Report 2026

Allergy Conjunctivitis Market Overview

• Allergy Conjunctivitis market size has reached to $2.63 billion in 2025 • Expected to grow to $3.51 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Driving Forces Behind Allergy Conjunctivitis Market Growth • Market Trend: Adoption Of Innovative Ophthalmic Formulations To Improve Allergy Conjunctivitis Treatment • North America was the largest region in 2025.

What Is Covered Under Allergy Conjunctivitis Market?

Allergy conjunctivitis is inflammation of the lining of the eye (conjunctiva) which is caused by an allergic reaction to substances like pollen or mold spores. Conjunctiva is the membrane or tissue that covers the inside of eyelids, as well as the white part of the eyeball. Symptoms of allergic conjunctivitis includes red, itchy, and watery eyes. The main drug class of allergy conjunctivitis are antihistamines and mast cell stabilizers, corticosteroids, and others. Antihistamine and mast cell stabilizers are prescriptions or over-the-counter medications that inhibit the physiological action of histamines. The diseases involved are mild and severe whose conjunctivitis are distributed through hospital pharmacies, drug stores, and retail pharmacies, and online pharmacies.

What Is The Allergy Conjunctivitis Market Growth Forecast?

The allergy conjunctivitis market size is expected to see strong growth in the next few years. It will grow to $3.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rising adoption of biologics and immunotherapies, growth of telemedicine and digital health platforms, expansion of e-commerce in pharmaceuticals, increased government initiatives for eye care, innovation in patient-specific drug delivery. Major trends in the forecast period include rising prevalence of seasonal allergies, increasing demand for non-steroidal treatments, growth of online pharmacy channels, awareness of eye health and preventive care, expansion of pediatric and geriatric allergy care.

Global Allergy Conjunctivitis Market Segmentation

1) By Drug Class: Antihistamines And Mast Cell Stabilizers, Corticosteroids, Other Drug Classes 2) By Disease Type: Mild, Severe 3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies Subsegments: 1) By Antihistamines And Mast Cell Stabilizers: Topical Antihistamines, Oral Antihistamines, Mast Cell Stabilizers 2) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids 3) By Other Drug Classes: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Combination Therapy, Immunotherapy, Leukotriene Receptor Antagonists

What Is The Driver Of The Allergy Conjunctivitis Market?

Prevalence of eye disorders is expected to propel the growth of the allergy conjunctivitis market. An eye disorder refers to any condition or abnormality that affects the structure or function of the eyes, leading to impaired vision or other symptoms related to eye health. Allergy conjunctivitis plays a significant role in the spectrum of eye disorders, particularly in cases where the condition is triggered by allergic reactions. This form of conjunctivitis is characterized by inflammation of the conjunctiva, the thin membrane covering the eye surface, and is commonly induced by exposure to allergens such as pollen, dust, or pet dander. The rise in environmental pollutants and chemicals has contributed to an increase in allergic conjunctivitis cases. For instance, in August 2023, the World Health Organization, a Switzerland-based specialized agency of the United Nations, published an article according to which globally, at least 2.2 billion people have a near or distance vision impairment, and among these 1 billion people, the main conditions causing distance vision impairment or blindness are cataracts (94 million), refractive error (88.4 million), age-related macular degeneration (8 million), glaucoma (7.7 million), and diabetic retinopathy (3.9 million). Therefore, prevalence in eye disorders is driving the allergy conjunctivitis industry.

Key Players In The Global Allergy Conjunctivitis Market

Major companies operating in the allergy conjunctivitis market are Allergan PLC, AbbVie Inc., Ajanta Pharma Limited, Akron Operating Company LLC, Alcon Inc., Alembic Pharmaceuticals Ltd., Atopix Therapeutics Ltd., Auven Therapeutics Management LLLP, Bausch & Lomb, Cipla Ltd., Grevis Pharmaceutical Private Limited, Indoco Remedies Ltd., Jabs Biotech Pvt. Ltd., JAWA Pharmaceuticals Pvt. Ltd., Novartis AG, Ocular Therapeutix Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Laboratoires Thea SAS, Aciex Therapeutics Inc., Bausch Health Companies Inc., C.H. Boehringer Sohn AG & Co. KG, Eyevance Pharmaceuticals LLC, Johnson & Johnson Services Inc., Mylan N.V., Nicox S.A., Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Shire PLC, Teva Pharmaceutical Industries Ltd., Zydus Cadila

Global Allergy Conjunctivitis Market Trends and Insights

Major companies are operating in the allergy conjunctivitis market, focusing on developing technological advancements such as eyelid-applied cream formulations for improved drug delivery, enhanced patient compliance, and reduced administration frequency. An eyelid-applied cream formulation is applied to the eyelids rather than directly into the eyes, allowing sustained release of antihistamines while minimizing irritation and improving adherence compared to traditional eye drops. For instance, in May 2024, Santen Pharmaceutical, a Japan-based ophthalmology company, launched Alesion Eyelid Cream 0.5%, designed for patients with allergic conjunctivitis. The product delivers epinastine hydrochloride via the eyelids, significantly reducing itching and redness, offers once-daily application, and provides a favorable safety profile over long-term use.

What Are Latest Mergers And Acquisitions In The Allergy Conjunctivitis Market?

In July 2023, Harrow Health, a US-based company focused on the ophthalmic healthcare market, acquired the branded ophthalmic portfolio of Santen Holdings U.S. Inc. This acquisition enables Harrow to advance its goal of becoming a leader in the top tier of U.S. ophthalmic pharmaceutical companies and makes its branded portfolio one of the most comprehensive in the U.S. market. Santen Holdings U.S. Inc. is a US-based ophthalmology and human eye health solutions provider.

Regional Insights

North America was the largest region in the allergy conjunctivitis market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Allergy Conjunctivitis Market?

The allergy conjunctivitis market consists of sales of therapeutics that are used to treat inflammation of eyes caused due to allergens. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Allergy Conjunctivitis Market Report 2026?

The allergy conjunctivitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the allergy conjunctivitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.